Russell Investments Group
ABVX

Russell Investments Group’s Abivax ABVX Stock Holding History

Russell Investments Group’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.06M Sell
22,970
-42,303
-65% -$4.79M ﹤0.01% 1831
2026
Q1 		$7.27M Buy
65,273
+800
+1% +$94.7K 0.01% 1123
2025
Q4 		$8.69M Buy
64,473
+22,579
+54% +$2.46M 0.01% 1005
2025
Q3 		$3.56M Buy
+41,894
New +$2.57M ﹤0.01% 1517

Other funds holding ABVX

HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
NNPTE
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne Warszawa, Poland $1.83B AUM 331.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $646M AUM 291.07% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $295M AUM 40.98% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Russell Investments Group's ABVX Position: Q2 2026 in Review

Russell Investments Group reduced its Abivax (ABVX) stake by 65% in Q2 2026, selling an estimated $4.79M and leaving 22,970 shares worth $3.06M. The position accounts for ﹤0.01% of the portfolio, ranked #1831.

Russell Investments Group first reported a position in ABVX in Q3 2025 and has held it in 4 quarters since. The position peaked at $8.69M in Q4 2025. 129 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Russell Investments Group held 22,970 shares of Abivax worth $3.06M as of Q2 2026.
  • Russell Investments Group sold 42,303 Abivax shares in Q2 2026, an estimated $4.79M.
  • Abivax made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #1831 holding.
  • Russell Investments Group first reported a position in Abivax in Q3 2025 and has held it in 4 quarters since.
  • Russell Investments Group's Abivax position peaked at $8.69M in Q4 2025.
  • 129 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.